About Atsushi Usami
Form D filings for Violet Therapeutics in 2023 list Atsushi Usami as director.
Atsushi Usami first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Atsushi Usami in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Atsushi Usami works with at each company, as listed on that company's latest Form D.
Violet Therapeutics, Inc. · Form D, May 5, 2023
WY
William Yelle
Executive officer and director
MF
Meredith Fisher
Chief Executive Officer and director
JB
Jonathan Behr
Director